Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the long-term safety and efficacy of TAU-284 (Bepotastine besilate) in pediatric patients with perennial allergic rhinitis for 12 weeks administration.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tanabe Pharma Corporation
NCT01425632 · Perennial Allergic Rhinitis
NCT07231861 · Bronchial Asthma, Perennial Allergic Rhinitis
NCT05299086 · Perennial Allergic Rhinitis, Child, Only
NCT00732368 · Perennial Allergic Rhinitis
NCT06180083 · Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis
Reserch site
Kanagawa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions